Quick Answer
MYRIAD GENETICS INC reported Gross Profit of $576.60 million for the year ending 2025.
- MYRIAD GENETICS INC showed a decrease of -1.5% in Gross Profit from 2024 to 2025.
- This data is from MYRIAD GENETICS INC's annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2024: $137.60 million | Q2 2024: $147.10 million | Q3 2024: $149.80 million | Q1 2025: $134.20 million | Q2 2025: $151.80 million | Q3 2025: $143.80 million.
- Over the full 4 years of available data (2022 to 2025), MYRIAD GENETICS INC's Gross Profit has grown by 21.0%.
- Historical annual values: Fiscal year 2025: $576.60 million | Fiscal year 2024: $585.40 million | Fiscal year 2023: $517.00 million | Fiscal year 2022: $476.40 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: